SCHEMBL2373679

SCHEMBL2373679

COc1ccc(-c2cc[c]c(OC)c2OC)c(OC)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.46
CYP1B1 Q16678 5/20 0.46
CYP3A4 P08684 3/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2E1 P05181 1/20 0.46
CYP2C8 P10632 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2A6 P11509 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP4B1 P13584 1/20 0.46
CYP2B6 P20813 1/20 0.46
CYP3A5 P20815 1/20 0.46
CYP2A7 P20853 1/20 0.46
CYP3A7 P24462 1/20 0.46
CYP2F1 P24903 1/20 0.46
CYP2C18 P33260 1/20 0.46
CYP2C19 P33261 1/20 0.46
CYP2J2 P51589 1/20 0.46
CYP4F2 P78329 1/20 0.46
CYP4F8 P98187 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9211522 0.81 ADORA3 (0.39) HTTADORA3KDM4ELMNA
SCHEMBL6189334 0.81 CYP1A1 (0.46) CYP1A1CYP1B1CYP3A4CYP1A2CYP2E1
SCHEMBL1587900 0.79 APP (0.42) CYP3A4CYP1A2CYP2C9CYP2C19CA12
SCHEMBL2598020 0.78 CYP1A1 (0.49) CYP1A1CYP1B1CYP3A4CYP1A2CYP2E1
SCHEMBL29589241 0.77 CYP1A1 (0.69) CYP1A1CYP1B1CYP3A4CYP1A2CYP2E1
SCHEMBL196689 0.77 CYP1A1 (0.69) CYP1A1CYP1B1CYP3A4CYP1A2CYP2E1
SCHEMBL11523594 0.77 CYP1A1 (0.51) CYP1A1CYP1B1CYP3A4CYP1A2CYP2E1
SCHEMBL2598021 0.74 CYP1A1 (0.49) CYP1A1CYP1B1CYP3A4CYP1A2CYP2E1
SCHEMBL11116451 0.74 CYP1A1 (0.49) CYP1A1CYP1B1CYP3A4CYP1A2CYP2E1
SCHEMBL6189588 0.73 CYP1A1 (0.51) CYP1A1CYP1B1CYP3A4CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024061614-A1 ACTIVE INGREDIENT COMBINATIONS FROM ALKYLAMIDOTHIAZOLES AND ONE OR MORE BIOPOLYMERS BEIERSDORF AG (DE) 2024-03-28 WO claimed
WO-2021104782-A1 USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE CARE OF TATTOOED HUMAN SKIN AND IN PARTICULAR FOR INCREASING BRILLIANCY OF TATTOOS ON DARK HUMAN SKIN BEIERSDORF AG (DE) 2021-06-03 WO claimed
EP-3820436-A1 SELF-ADHESIVE FLAT PRODUCTS CONTAINING ONE OR MORE ALKYLAMIDOTHIAZOLES Beiersdorf AG (DE) 2021-05-19 EP claimed
WO-2020011470-A1 SELF-ADHESIVE FLAT PRODUCTS CONTAINING ONE OR MORE ALKYLAMIDOTHIAZOLES BEIERSDORF AG (DE) 2020-01-16 WO claimed
US-10245252-B2 Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin BEIERSDORF AG (DE) 2019-04-02 US claimed
WO-2018137854-A1 ACTIVE INGREDIENT COMBINATIONS CONSISTING OF TRANS-4-T-BUTYLCYCLOHEXANOL AND ONE OR MORE ALKYLAMIDOTHIAZOLES AS WELL AS COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE INGREDIENT COMBINATIONS BEIERSDORF AG (DE) 2018-08-02 WO claimed
EP-3176156-A1 ALKYLAMIDOTHIAZOLES, COSMETIC AND DERMATOLOGICAL PREPARATIONS CONTAINING THEM, AND THEIR USE FOR THE TREATMENT AND PROPHYLAXIS OF UNWANTED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2017-06-07 EP claimed
US-9610234-B2 Combinations of alkylamidothiazoles and preservatives BEIERSDORF AG (DE) 2017-04-04 US claimed
US-20160324832-A1 USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN BEIERSDORF AG (DE) 2016-11-10 US claimed
EP-3082752-A1 USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN Beiersdorf AG (DE) 2016-10-26 EP claimed
WO-2014139759-A1 COMPOSITIONS CONSISTING OF ALKYLAMIDOTHIAZOLES AND UV-FILTER SUBSTANCES BEIERSDORF AG (DE) 2014-09-18 WO claimed
EP-2758383-A1 AROMATIC AMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID AROMATIC AMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2014-07-30 EP claimed
EP-2758381-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2014-07-30 EP claimed
EP-2758382-A1 HETEROCYCLOCARBONYLAMINOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID HETEROCYCLOCARBONYLAMINOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN Beiersdorf AG (DE) 2014-07-30 EP claimed
WO-2013041537-A1 HETEROCYCLOCARBONYLAMINOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID HETEROCYCLOCARBONYLAMINOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2013-03-28 WO claimed
WO-2013041526-A1 ALKYLAMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ALKYLAMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2013-03-28 WO claimed
WO-2013041535-A1 AROMATIC AMIDOTHIAZOLES, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID AROMATIC AMIDOTHIAZOLES, AND USE THEREOF TO COMBAT OR PREVENT UNDESIRED PIGMENTATION OF THE SKIN BEIERSDORF AG (DE) 2013-03-28 WO claimed
US-20130039870-A1 Cosmetic Or Dermatological Preparations With A Content Of One Or More Thiazole Derivates BEIERSDORF AG (DE) 2013-02-14 US claimed
EP-2549979-A2 COSMETIC OR DERMATOLOGICAL PREPARATIONS WITH A CONTENT OF ONE OR MORE THIAZOLE DERIVATIVES Beiersdorf AG (DE) 2013-01-30 EP claimed
WO-2011117034-A2 COSMETIC OR DERMATOLOGICAL PREPARATIONS WITH A CONTENT OF ONE OR MORE THIAZOLE DERIVATIVES BEIERSDORF AG (DE) 2011-09-29 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130039870-A1 Cosmetic Or Dermatological Preparations With A Content Of One Or More Thiazole Derivates TYR, CUTA, MITF CYP1A1 908/4885CYP1B1 690/4885CYP3A4 1481/4885
US-10245252-B2 Use of alkylamidothiazoles in cosmetic or dermatological preparations for the prophylaxis or treatment of sensitive skin CUTA, TYR, AADAC CYP1A1 760/4885CYP1B1 494/4885CYP3A4 1293/4885
US-20160324832-A1 USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE PROPHYLAXIS OR TREATMENT OF SENSITIVE SKIN CUTA, TYR, AADAC CYP1A1 760/4885CYP1B1 494/4885CYP3A4 1293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.